Another step in the ongoing battle between Galderma and Mylan over the right to manufacture generic Oracea. A judge has declared that Mylan infringes 1 of the patents that protects Oracea from generic copies. Some History …
oracea articles ↓
Mylan Violates The Chang Patent for Oracea
August 30th, 2011, by David Pascoe | oracea, patents
Metrogel, Finacea and Oracea are Best for Rosacea
July 15th, 2011, by David Pascoe | finacea, metrogel, oracea
A systematic review of the available rosacea research confirms that Metrogel, Finacea and Oracea are effective for moderate to severe rosacea. One study further found cyclosporine 0.05% ophthalmic emulsion effective for ocular rosacea. This review looked at the published results of 58 trials to note bias and construct a high level summary of the results. No Surprises Here It will come as …
Galderma blocking Impax making Generic Oracea
June 13th, 2011, by David Pascoe | oracea
The last we heard from Impax Laboratories was in late 2009 when they had filed an Abbreviated New Drug Application (ANDA 91-447) to produce a generic version of Oracea. …
LA Clinic looking for Oracea Biomarkers Study Participants
April 28th, 2011, by David Pascoe | clinical trials, oracea
The Vitligo and Pigmentation Institute of Southern California is hosting part of the trial to evaluate Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea vs Placebo. This trial is looking to prove changes in inflammatory markers like the peptide LL-37 and the MMP family match the improvement seen when taking Oracea. The trial is scheduled to involve 170 participants at …
Generic Oracea Legal Trial now in July 2011
April 12th, 2011, by David Pascoe | oracea
I have been watching for a while to see for any developments in the legal proceedings between Mylan and Galderma. These proceedings will determine whether Mylan is allowed to sell Generic Oracea. This is of interest to many rosacea sufferers who consider that Oracea is too …
